Eclipsys posts revenue growth in 2Q
Eclipsys Corp. says it is "pleased with the progress" it continues to make as it released its financial results of the second quarter.
Revenue climbed to $73.6 million, compared with $63.4 million in the first quarter of 2003. The company also reported a net loss of $10 million, compared with a net loss of 11 million in the year-ago quarter.
According to Paul Ruflin, Eclipsys' president and CEO, the company expects continued revenue over the next two quarters due to the recent launch of the latest release of Sunrise Clinical Manager 3.5 XA.
Revenue climbed to $73.6 million, compared with $63.4 million in the first quarter of 2003. The company also reported a net loss of $10 million, compared with a net loss of 11 million in the year-ago quarter.
According to Paul Ruflin, Eclipsys' president and CEO, the company expects continued revenue over the next two quarters due to the recent launch of the latest release of Sunrise Clinical Manager 3.5 XA.